vs
Gitlab Inc.（GTLB）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
Gitlab Inc.的季度营收约是再鼎医药的1.9倍（$244.4M vs $127.1M），Gitlab Inc.同比增速更快（24.6% vs 17.1%），Gitlab Inc.自由现金流更多（$28.4M vs $-26.7M），过去两年Gitlab Inc.的营收复合增速更高（22.1% vs 20.8%）
GitLab Inc.是一家美国企业，开发并运营同名开放核心架构DevOps软件平台，覆盖软件开发、安全防护、运维运营全流程。产品基于Git分布式版本控制技术搭建，还为各项目提供访问控制、缺陷追踪、需求管理、任务调度、项目知识库、代码片段分享等全栈协作功能。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
GTLB vs ZLAB — 直观对比
营收规模更大
GTLB
是对方的1.9倍
$127.1M
营收增速更快
GTLB
高出7.5%
17.1%
自由现金流更多
GTLB
多$55.1M
$-26.7M
两年增速更快
GTLB
近两年复合增速
20.8%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $244.4M | $127.1M |
| 净利润 | $-8.3M | — |
| 毛利率 | 86.8% | 51.0% |
| 营业利润率 | -5.1% | -54.6% |
| 净利率 | -3.4% | — |
| 营收同比 | 24.6% | 17.1% |
| 净利润同比 | -128.0% | — |
| 每股收益（稀释后） | $-0.05 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GTLBZLAB
| Q4 25 | $244.4M | $127.1M | ||
| Q3 25 | $236.0M | $115.4M | ||
| Q2 25 | $214.5M | $109.1M | ||
| Q1 25 | $211.4M | $105.7M | ||
| Q4 24 | $196.0M | $108.5M | ||
| Q3 24 | $182.6M | $101.8M | ||
| Q2 24 | $169.2M | $100.1M | ||
| Q1 24 | $163.8M | $87.1M |
净利润GTLBZLAB
| Q4 25 | $-8.3M | — | ||
| Q3 25 | $-9.2M | $-36.0M | ||
| Q2 25 | $-35.9M | $-40.7M | ||
| Q1 25 | $5.8M | $-48.4M | ||
| Q4 24 | $29.6M | — | ||
| Q3 24 | $12.9M | $-41.7M | ||
| Q2 24 | $-54.6M | $-80.3M | ||
| Q1 24 | $-36.5M | $-53.5M |
毛利率GTLBZLAB
| Q4 25 | 86.8% | 51.0% | ||
| Q3 25 | 87.9% | 59.5% | ||
| Q2 25 | 88.3% | 60.6% | ||
| Q1 25 | 89.2% | 63.6% | ||
| Q4 24 | 88.7% | 61.5% | ||
| Q3 24 | 88.3% | 64.1% | ||
| Q2 24 | 88.9% | 64.9% | ||
| Q1 24 | 90.2% | 61.4% |
营业利润率GTLBZLAB
| Q4 25 | -5.1% | -54.6% | ||
| Q3 25 | -7.8% | -42.3% | ||
| Q2 25 | -16.1% | -50.3% | ||
| Q1 25 | -9.1% | -53.3% | ||
| Q4 24 | -14.7% | -62.6% | ||
| Q3 24 | -22.5% | -66.6% | ||
| Q2 24 | -31.7% | -76.0% | ||
| Q1 24 | -21.3% | -80.7% |
净利率GTLBZLAB
| Q4 25 | -3.4% | — | ||
| Q3 25 | -3.9% | -31.2% | ||
| Q2 25 | -16.7% | -37.3% | ||
| Q1 25 | 2.7% | -45.8% | ||
| Q4 24 | 15.1% | — | ||
| Q3 24 | 7.1% | -40.9% | ||
| Q2 24 | -32.3% | -80.2% | ||
| Q1 24 | -22.3% | -61.4% |
每股收益（稀释后）GTLBZLAB
| Q4 25 | $-0.05 | $-0.05 | ||
| Q3 25 | $-0.06 | $-0.03 | ||
| Q2 25 | $-0.22 | $-0.04 | ||
| Q1 25 | $0.05 | $-0.04 | ||
| Q4 24 | $0.18 | $-0.09 | ||
| Q3 24 | $0.08 | $-0.04 | ||
| Q2 24 | $-0.35 | $-0.08 | ||
| Q1 24 | $-0.23 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $224.2M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $922.7M | $715.5M |
| 总资产 | $1.6B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GTLBZLAB
| Q4 25 | $224.2M | $689.6M | ||
| Q3 25 | $261.4M | $717.2M | ||
| Q2 25 | $255.7M | $732.2M | ||
| Q1 25 | $227.6M | $757.3M | ||
| Q4 24 | $176.6M | $779.7M | ||
| Q3 24 | $438.6M | $616.1M | ||
| Q2 24 | $420.3M | $630.0M | ||
| Q1 24 | $288.0M | $650.8M |
股东权益GTLBZLAB
| Q4 25 | $922.7M | $715.5M | ||
| Q3 25 | $866.6M | $759.9M | ||
| Q2 25 | $808.3M | $791.7M | ||
| Q1 25 | $775.9M | $810.8M | ||
| Q4 24 | $724.7M | $840.9M | ||
| Q3 24 | $642.8M | $667.7M | ||
| Q2 24 | $567.8M | $704.2M | ||
| Q1 24 | $571.2M | $762.2M |
总资产GTLBZLAB
| Q4 25 | $1.6B | $1.2B | ||
| Q3 25 | $1.5B | $1.2B | ||
| Q2 25 | $1.4B | $1.2B | ||
| Q1 25 | $1.4B | $1.2B | ||
| Q4 24 | $1.3B | $1.2B | ||
| Q3 24 | $1.4B | $985.3M | ||
| Q2 24 | $1.3B | $987.4M | ||
| Q1 24 | $1.3B | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $31.4M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $28.4M | $-26.7M |
| 自由现金流率自由现金流/营收 | 11.6% | -21.0% |
| 资本支出强度资本支出/营收 | 1.2% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $242.3M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流GTLBZLAB
| Q4 25 | $31.4M | $-26.0M | ||
| Q3 25 | $49.4M | $-32.0M | ||
| Q2 25 | $106.3M | $-31.0M | ||
| Q1 25 | $63.2M | $-61.7M | ||
| Q4 24 | $-177.0M | $-55.8M | ||
| Q3 24 | $11.7M | $-26.8M | ||
| Q2 24 | $38.1M | $-42.2M | ||
| Q1 24 | $24.9M | $-90.1M |
自由现金流GTLBZLAB
| Q4 25 | $28.4M | $-26.7M | ||
| Q3 25 | $46.5M | $-35.0M | ||
| Q2 25 | $105.4M | $-33.9M | ||
| Q1 25 | $62.1M | $-63.2M | ||
| Q4 24 | $-178.1M | $-58.4M | ||
| Q3 24 | $10.8M | $-28.2M | ||
| Q2 24 | $37.4M | $-42.9M | ||
| Q1 24 | $24.5M | $-91.1M |
自由现金流率GTLBZLAB
| Q4 25 | 11.6% | -21.0% | ||
| Q3 25 | 19.7% | -30.4% | ||
| Q2 25 | 49.1% | -31.1% | ||
| Q1 25 | 29.4% | -59.9% | ||
| Q4 24 | -90.8% | -53.8% | ||
| Q3 24 | 5.9% | -27.7% | ||
| Q2 24 | 22.1% | -42.9% | ||
| Q1 24 | 15.0% | -104.5% |
资本支出强度GTLBZLAB
| Q4 25 | 1.2% | 0.5% | ||
| Q3 25 | 1.2% | 2.6% | ||
| Q2 25 | 0.4% | 2.6% | ||
| Q1 25 | 0.5% | 1.5% | ||
| Q4 24 | 0.5% | 2.4% | ||
| Q3 24 | 0.5% | 1.3% | ||
| Q2 24 | 0.4% | 0.7% | ||
| Q1 24 | 0.2% | 1.1% |
现金转化率GTLBZLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 10.89× | — | ||
| Q4 24 | -5.99× | — | ||
| Q3 24 | 0.90× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GTLB
| Subscription And Circulation | $146.4M | 60% |
| Subscription Software As A Service | $76.9M | 31% |
| License | $15.5M | 6% |
| Professional Services And Other | $5.6M | 2% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
